Literature DB >> 14607264

Contractile role of M2 and M3 muscarinic receptors in gastrointestinal, airway and urinary bladder smooth muscle.

Frederick J Ehlert1.   

Abstract

Both M(2) and M(3) muscarinic receptors are expressed in smooth muscle and influence contraction through distinct signaling pathways. M(3) receptors interact with G(q) to trigger phosphoinositide hydrolysis, Ca(2+) mobilization and a direct contractile response. In contrast, M(2) receptors interact with G(i) and G(o) to inhibit adenylyl cyclase and Ca(2+)-activated K(+) channels and to potentiate a Ca(2+)-dependent, nonselective cation conductance. Ultimately, these mechanisms lead to the prediction that the influence of the M(2) receptor on contraction should be conditional upon mobilization of Ca(2+) by another receptor such as the M(3). Mathematical modeling studies of these mechanisms show that the competitive antagonism of a muscarinic response mediated through activation of both M(2) and M(3) receptors should resemble the profile of the directly acting receptor (i.e., the M(3)) and not that of the conditionally acting receptor (i.e., the M(2)). Using a combination of pharmacological and genetic approaches, we have identified two mechanisms for the M(2) receptor in contraction: 1) a high potency inhibition of the relaxation elicited by agents that increase cytosolic cAMP and 2) a low potency potentiation of contractions elicited by the M(3) receptor. The latter mechanism may be involved in muscarinic agonist-mediated heterologous desensitization of smooth muscle, which requires activation of both M(2) and M(3) receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607264     DOI: 10.1016/j.lfs.2003.09.023

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  32 in total

1.  Impaired M3 and enhanced M2 muscarinic receptor contractile function in a streptozotocin model of mouse diabetic urinary bladder.

Authors:  K J Pak; R S Ostrom; M Matsui; F J Ehlert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

2.  Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing.

Authors:  Kylie J Mansfield; Lu Liu; Frederick J Mitchelson; Kate H Moore; Richard J Millard; Elizabeth Burcher
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

Review 3.  Big-conductance Ca2+-activated K+ channels in physiological and pathophysiological urinary bladder smooth muscle cells.

Authors:  Shankar P Parajuli; Yun-Min Zheng; Robert Levin; Yong-Xiao Wang
Journal:  Channels (Austin)       Date:  2016-04-21       Impact factor: 2.581

4.  Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M4 Muscarinic Receptor as a Novel Therapeutic Target.

Authors:  Rocco G Gogliotti; Nicole M Fisher; Branden J Stansley; Carrie K Jones; Craig W Lindsley; P Jeffrey Conn; Colleen M Niswender
Journal:  J Pharmacol Exp Ther       Date:  2018-03-09       Impact factor: 4.030

5.  Expression and alteration of BKCa channels in the sphincter of Oddi's from rabbits with hypercholesterolemia.

Authors:  Dan Feng; Haiyan Nan; Wen Wang; Linfeng Yan; Pang Du; Lin Zuo; Kun Zhang; Minggao Zhao; Guangbin Cui
Journal:  Channels (Austin)       Date:  2017-01-19       Impact factor: 2.581

6.  Novel M2 -selective, Gi -biased agonists of muscarinic acetylcholine receptors.

Authors:  Alena Randáková; Dominik Nelic; Dana Ungerová; Peter Nwokoye; Qiwen Su; Vladimír Doležal; Esam E El-Fakahany; John Boulos; Jan Jakubík
Journal:  Br J Pharmacol       Date:  2020-02-15       Impact factor: 8.739

7.  Activation of muscarinic M3 receptors inhibits large-conductance voltage- and Ca2+-activated K+ channels in rat urinary bladder smooth muscle cells.

Authors:  Shankar P Parajuli; Georgi V Petkov
Journal:  Am J Physiol Cell Physiol       Date:  2013-05-22       Impact factor: 4.249

8.  Pharmacological analysis of the interaction of antimuscarinic drugs at M(2) and M(3) muscarinic receptors in vivo using the pithed rat assay.

Authors:  Scott R Armstrong; Sergio Briones; Brian Horger; Carrie L Richardson; Sarah Jaw-Tsai; Sharath S Hegde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-07       Impact factor: 3.000

Review 9.  Purinergic signalling in the urinary tract in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

10.  Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors.

Authors:  Jan Jakubík; Alena Randáková; Esam E El-Fakahany; Vladimír Dolezal
Journal:  BMC Pharmacol       Date:  2009-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.